MedPath

Effect of osteoporosis therapy with RANKL inhibitor on coronary calcifications

Not Applicable
Conditions
coronary artery disease
Registration Number
JPRN-UMIN000026938
Lead Sponsor
Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
11
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients who can not receive coronary CT 2. Patients with hypocalcemia 3. Patients with allergy to denosumab 4. Patients who will receive tooth extraction in a few days 5. Patients with the expected rest of their life less than 1 year 6. Patients with alcohol/drug dependence during the past 3 months 7. Patients without informed consent 8. Pregnant or possibly pregnant females 9. Patients with latex allergy 10. Patients judged inappropriate for this study by phisician 11. Patients without agreement

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath